Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_assertion type Assertion NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_head.
- NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_assertion wasGeneratedBy ECO_0000203 NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_provenance.
- NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_assertion wasDerivedFrom befree-20140225 NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_provenance.
- NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_assertion SIO_000772 23470485 NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_provenance.
- NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_assertion evidence source_evidence_literature NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_provenance.
- NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_assertion description "[The selectivity of TRAIL towards cancer cells has promoted clinical evaluation of recombinant human TRAIL (rhTRAIL) and its agonistic antibodies in treating several major human cancers including colon and non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348082.RAqCqcRyldKdCPEOdlIE82s6QJFvocHJ3JypTU3YcykMI130_provenance.